REDWOOD CITY, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its ...
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The virus that causes COVID-19, SARS-CoV-2, rarely ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of ...
New England Biolabs (NEB®) announced today that they have released a novel, thermostable reverse transcriptase, WarmStart® RTx Reverse Transcriptase, specifically designed for nucleic acid detection.
We performed a comparative study of detection of micrometastases using immunohistochemistry (IHC) by anti-cytokeratin antibody and carcinoembryonic antigen (CEA)-specific reverse-transcriptase ...
Studies will need to validate, in a new patient cohort, the prognostic utility of GUCY2C qRT-PCR for categorical identification (yes/no) of occult metastases as a marker of disease recurrence. This ...
Researchers at the Chan Zuckerberg Biohub, San Francisco, and collaborators have warned against only targeting one viral gene when carrying out reverse transcriptase-polymerase chain reaction (RT-PCR) ...
Malaria is a significant health issue, particularly across subtropical and tropical environments. This means that rapid diagnosis in anyone who is suspected to have the disease is of the upmost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback